MicroRNAs as early toxicity signatures of doxorubicin in human-induced pluripotent stem cell-derived cardiomyocytes
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1432-0738
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
MicroRNAs as early toxicity signatures of doxorubicin in human-induced pluripotent stem cell-derived cardiomyocytes ; volume:90 ; number:12 ; day:3 ; month:2 ; year:2016 ; pages:3087-3098 ; date:12.2016
Archives of toxicology ; 90, Heft 12 (3.2.2016), 3087-3098, 12.2016
- Urheber
-
Chaudhari, Umesh
- Beteiligte Personen und Organisationen
-
Nemade, Harshal
Gaspar, John Antonydas
Hescheler, Jürgen
Hengstler, Jan G.
Sachinidis, Agapios
SpringerLink (Online service)
- DOI
-
10.1007/s00204-016-1668-0
- URN
-
urn:nbn:de:1111-2016120311542
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:58 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Chaudhari, Umesh
- Nemade, Harshal
- Gaspar, John Antonydas
- Hescheler, Jürgen
- Hengstler, Jan G.
- Sachinidis, Agapios
- SpringerLink (Online service)
Ähnliche Objekte (12)
Functional cardiotoxicity assessment of cosmetic compounds using human-induced pluripotent stem cell-derived cardiomyocytes
Control mechanisms of carcinogenesis
From bisphenol A to bisphenol F and a ban of mustard due to chronic low-dose exposures?
Essential components of methods papers
Conflict of interest Statements : current dilemma and a possible way forward
Highlight report : towards the replacement of in vivo repeated dose systemic toxicity testing
Modeling short QT syndrome using human‐induced pluripotent stem cell–derived cardiomyocytes
Overexpression of KCNJ2 enhances maturation of human-induced pluripotent stem cell-derived cardiomyocytes
Cardiomyopathy phenotypes in human-induced pluripotent stem cell-derived cardiomyocytes—a systematic review
Cell death mechanisms of the anti-cancer drug etoposide on human cardiomyocytes isolated from pluripotent stem cells
Embryonic stem cell-derived cardiomyocytes for the treatment of doxorubicin-induced cardiomyopathy
Toxikologie - Wurzeln und Wandel
Functional cardiotoxicity assessment of cosmetic compounds using human-induced pluripotent stem cell-derived cardiomyocytes
Control mechanisms of carcinogenesis
From bisphenol A to bisphenol F and a ban of mustard due to chronic low-dose exposures?
Essential components of methods papers
Conflict of interest Statements : current dilemma and a possible way forward
Highlight report : towards the replacement of in vivo repeated dose systemic toxicity testing
Modeling short QT syndrome using human‐induced pluripotent stem cell–derived cardiomyocytes
Overexpression of KCNJ2 enhances maturation of human-induced pluripotent stem cell-derived cardiomyocytes
Cardiomyopathy phenotypes in human-induced pluripotent stem cell-derived cardiomyocytes—a systematic review
Cell death mechanisms of the anti-cancer drug etoposide on human cardiomyocytes isolated from pluripotent stem cells
Embryonic stem cell-derived cardiomyocytes for the treatment of doxorubicin-induced cardiomyopathy
Toxikologie - Wurzeln und Wandel
Functional cardiotoxicity assessment of cosmetic compounds using human-induced pluripotent stem cell-derived cardiomyocytes
Control mechanisms of carcinogenesis
From bisphenol A to bisphenol F and a ban of mustard due to chronic low-dose exposures?
Essential components of methods papers
Conflict of interest Statements : current dilemma and a possible way forward
Highlight report : towards the replacement of in vivo repeated dose systemic toxicity testing
Modeling short QT syndrome using human‐induced pluripotent stem cell–derived cardiomyocytes
Overexpression of KCNJ2 enhances maturation of human-induced pluripotent stem cell-derived cardiomyocytes
Cardiomyopathy phenotypes in human-induced pluripotent stem cell-derived cardiomyocytes—a systematic review
Cell death mechanisms of the anti-cancer drug etoposide on human cardiomyocytes isolated from pluripotent stem cells
Embryonic stem cell-derived cardiomyocytes for the treatment of doxorubicin-induced cardiomyopathy